$783 Million is the total value of Rhenman & Partners Asset Management AB's 94 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARNA | New | Arena Pharmaceuticals Inc Reg | $14,522,000 | – | 569,491 | +100.0% | 1.85% | – |
| BSX | New | Boston Scientific Corp | $8,181,000 | – | 280,468 | +100.0% | 1.04% | – |
| LOXO | New | Loxo Oncology Inc | $6,909,000 | – | 75,000 | +100.0% | 0.88% | – |
| MYOK | New | MyoKardia Inc Reg | $6,465,000 | – | 150,872 | +100.0% | 0.82% | – |
| JUNO | New | Juno Therapeutics Inc | $4,486,000 | – | 100,000 | +100.0% | 0.57% | – |
| NVO | New | Novo Nordisk AS ADR Repr 1 Share Badr | $3,852,000 | – | 80,000 | +100.0% | 0.49% | – |
| DERM | New | Dermira Inc Reg | $2,700,000 | – | 100,000 | +100.0% | 0.34% | – |
| RARX | New | Ra Pharmaceuticals Inc Reg | $1,748,000 | – | 119,697 | +100.0% | 0.22% | – |
| NLNK | New | NewLink Genetics Corp | $1,018,000 | – | 100,000 | +100.0% | 0.13% | – |
| AGIO | New | Agios Pharmaceuticals Inc | $1,001,000 | – | 15,000 | +100.0% | 0.13% | – |
| New | Janus Henderson Group Plc Regnote | $472,000 | – | 13,556 | +100.0% | 0.06% | – | |
| SYMC | New | Symantec Corp | $307,000 | – | 9,359 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-10-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.